EP Patent

EP4171539A4 — COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE

Assigned to LA PharmaTech Inc · Expires 2024-01-17 · 2y expired

What this patent protects

Patent listed against azelastine-hydrochloride.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP4171539A4
Jurisdiction: EP
Classification: —
Expires: 2024-01-17
Drug substance claim: No
Drug product claim: No
Assignee: LA PharmaTech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.